ARCH Venture Fund IX, L.P. 13D and 13G filings for Sana Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:12 pm Purchase | 2024-09-30 | 13G | Sana Biotechnology, Inc. SANA | ARCH Venture Fund IX, L.P. | 46,028,125 20.600% | 1,883,181 (+4.27%) | Filing |
| 2024-02-09 5:35 pm Purchase | 2023-12-31 | 13G | Sana Biotechnology, Inc. SANA | ARCH Venture Fund IX, L.P. | 44,144,944 22.400% | 65,536 (+0.15%) | Filing |
| 2023-02-13 4:07 pm Purchase | 2022-12-31 | 13G | Sana Biotechnology, Inc. SANA | ARCH Venture Fund IX, L.P. | 44,079,408 23.100% | 817 (+0.00%) | Filing |
| 2022-02-10 5:12 pm Purchase | 2021-12-31 | 13G | Sana Biotechnology, Inc. SANA | ARCH Venture Fund IX, L.P. | 44,078,591 23.300% | 44,078,591 (New Position) | Filing |